1. Wang, Chun, Chen, Zhihang, Yi, Yun, Chang, Ying, Zhao, Qiu. 2023. RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4. In Oncogene, 43, 328-340. doi:10.1038/s41388-023-02902-4. https://pubmed.ncbi.nlm.nih.gov/38040804/
2. van der Zee, Julie, Dillen, Lubina, Baradaran-Heravi, Yalda, Engelborghs, Sebastiaan, Van Broeckhoven, Christine. 2021. Family-based exome sequencing identifies RBM45 as a possible candidate gene for frontotemporal dementia and amyotrophic lateral sclerosis. In Neurobiology of disease, 156, 105421. doi:10.1016/j.nbd.2021.105421. https://pubmed.ncbi.nlm.nih.gov/34118419/
3. Lv, Yuesheng, Sun, Siwen, Zhang, Jinrui, Wang, Yang, Li, Man. 2024. Loss of RBM45 inhibits breast cancer progression by reducing the SUMOylation of IRF7 to promote IFNB1 transcription. In Cancer letters, 596, 216988. doi:10.1016/j.canlet.2024.216988. https://pubmed.ncbi.nlm.nih.gov/38797234/
4. Choi, Seung H, Flamand, Mathieu N, Liu, Bei, Al-Hashimi, Hashim M, Meyer, Kate D. . RBM45 is an m6A-binding protein that affects neuronal differentiation and the splicing of a subset of mRNAs. In Cell reports, 40, 111293. doi:10.1016/j.celrep.2022.111293. https://pubmed.ncbi.nlm.nih.gov/36044854/
5. Bakkar, Nadine, Kousari, Arianna, Kovalik, Tina, Li, Yang, Bowser, Robert. 2015. RBM45 Modulates the Antioxidant Response in Amyotrophic Lateral Sclerosis through Interactions with KEAP1. In Molecular and cellular biology, 35, 2385-99. doi:10.1128/MCB.00087-15. https://pubmed.ncbi.nlm.nih.gov/25939382/
6. Collins, Mahlon, Riascos, David, Kovalik, Tina, Traynor, Bryan J, Bowser, Robert. 2012. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients. In Acta neuropathologica, 124, 717-32. doi:10.1007/s00401-012-1045-x. https://pubmed.ncbi.nlm.nih.gov/22993125/
智鼠故事 
